As of close of business last night, Opgen Inc’s stock clocked out at $0.71, down -8.96% from its previous closing price of $0.78. In other words, the price has decreased by -$0.0699 from its previous closing price. On the day, 595677 shares were traded.
Ratios:
To gain a deeper understanding of OPGN’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.18 and its Current Ratio is at 0.28. In the meantime, Its Debt-to-Equity ratio is 4.68 whereas as Long-Term Debt/Eq ratio is at 1.06.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Alliance Global Partners on March 01, 2019, initiated with a Buy rating and assigned the stock a target price of $2.30.
On February 07, 2018, H.C. Wainwright reiterated its Buy rating and also lowered its target price recommendation from $1 to $9.
On June 29, 2016, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $2.50.Rodman & Renshaw initiated its Buy rating on June 29, 2016, with a $2.50 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OPGN now has a Market Capitalization of 8.45M and an Enterprise Value of 20.71M. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.32 while its Price-to-Book (P/B) ratio in mrq is 2.66. Its current Enterprise Value per Revenue stands at 6.74 whereas that against EBITDA is -0.92.
Stock Price History:
Over the past 52 weeks, OPGN has reached a high of $3.84, while it has fallen to a 52-week low of $0.17. The 50-Day Moving Average of the stock is 0.4990, while the 200-Day Moving Average is calculated to be 0.4764.
Shares Statistics:
It appears that OPGN traded 1.74M shares on average per day over the past three months and 9.13M shares per day over the past ten days. A total of 10.01M shares are outstanding, with a floating share count of 9.97M. Insiders hold about 0.41% of the company’s shares, while institutions hold 2.68% stake in the company. Shares short for OPGN as of Mar 15, 2024 were 20.81k with a Short Ratio of 0.01, compared to 44.63k on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 0.21% and a Short% of Float of 0.21%.
Earnings Estimates
As of right now, 1 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$0.13 for the current quarter, with a high estimate of -$0.13 and a low estimate of -$0.13, while EPS last year was -$6. The consensus estimate for the next quarter is -$0.09, with high estimates of -$0.09 and low estimates of -$0.09.
Analysts are recommending an EPS of between -$10.37 and -$10.37 for the fiscal current year, implying an average EPS of -$10.37. EPS for the following year is -$0.29, with 1 analysts recommending between -$0.29 and -$0.29.
Revenue Estimates
In the current quarter, 1 analysts expect revenue to total $640k. It ranges from a high estimate of $640k to a low estimate of $640k. As of the current estimate, Opgen Inc’s year-ago sales were $722k, an estimated decrease of -11.40% from the year-ago figure.
A total of 1 analysts have provided revenue estimates for OPGN’s current fiscal year. The highest revenue estimate was $2.61M, while the lowest revenue estimate was $2.61M, resulting in an average revenue estimate of $2.61M. In the same quarter a year ago, actual revenue was $2.61M, up 0.10% from the average estimate. Based on 1 analysts’ estimates, the company’s revenue will be $2.6M in the next fiscal year. The high estimate is $2.6M and the low estimate is $2.6M. The average revenue growth estimate for next year is down -0.40% from the average revenue estimate for this year.
